Clinical Trials in Pittsburgh

Showing 2681-2700 of 18,076 trials

Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)

NCT00947583

This study is being conducted to determine the percentage of patients with solid spinal fusions after being treated with Osteocel Plus in a TLIF procedure. Due to the unique processing conditions, Osteocel Plus retains a high concentration of stem cells in conjunction with the allograft bone matrix, so it is hypothesized that the fusion rate with Osteocel Plus will be comparable to published data for autograft. The Osteocel product family has already been used in approximately 15,000 cases worldwide.

Degenerative Disc Disease

NuVasive19 participantsStarted May 2009

Pittsburgh, Pennsylvania, United States

RECRUITINGPhase 4< 1 mile

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

NCT06468202

The overall goal of this large, pragmatic, comparative effectiveness trial is to test the hypothesis that among at-risk individuals, 162 mg/day aspirin is superior to 81 mg/day in preventing Hypertensive disorders of pregnancy (HDP), and that there are multiple factors associated with adherence with aspirin therapy that will be important to identify to enable optimal implementation of study findings and population-level benefits.

Hypertensive Disorders of PregnancyPreeclampsiaGestational Hypertension

Ohio State University10,742 participantsStarted Oct 2024

Birmingham, Alabama, United States • Los Angeles, California, United States • San Francisco, California, United States +13 more locations

Osteocel® Plus in Transforaminal Lumbar Interbody Fusion (TLIF)

Effectiveness of Two Aspirin Doses for Prevention of Hypertensive Disorders of Pregnancy: ASPIRIN TRIAL

Find Trials by Condition in Pittsburgh

Stroke Thrombectomy and Aneurysm Registry

Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age

A Study of HBI-8000 (Tucidinostat) With Pembrolizumab in Non-Small Cell Lung Cancer

Let's Know!2: Language-focused Intervention for Children at Risk of Comprehension Difficulties

A Prospective Non-concurrent Controlled Evaluation of Open and MAS® PLIF

Clinical and Molecular Studies in Families With Inherited Eye Disease

Study of ARO-APOC3 in Healthy Volunteers, Hypertriglyceridemic Patients and Patients With Familial Chylomicronemia Syndrome (FCS)

Vancomycin Reduction Practices (VRP) in the NICU

Afimkibart (RO7790121) for the Treatment of Moderate to Severe Active Crohn's Disease

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD

An Observational Study of Patients With Moderate Parkinson's Disease

A Study of YL242 in Subjects With Advanced Solid Tumors

AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening

A Study to Investigate the Safety of OpCT-001 in Adults Who Have Primary Photoreceptor Disease (CLARICO)

A Study of DM919 Alone and in Combination With Pembrolizumab in Advanced Solid Tumors